تقرير
أعرض في EDS

TOFAcitinib Plus Hydroxycloroquine vs Hydroxycloroquine in Patients With COVID-19 Interstitial Pneumonia (TOFACoV-2)

التفاصيل البيبلوغرافية
العنوان: TOFAcitinib Plus Hydroxycloroquine vs Hydroxycloroquine in Patients With COVID-19 Interstitial Pneumonia (TOFACoV-2)
المؤلفون: Azienda Ospedaliera Ospedali Riuniti Marche Nord, Ospedale Civile Santo Spirito, Pescara, Università Magna Grecia, Catanzaro, ASST Papa Giovanni XXIII, Bergamo, Azienda Ospedaliero Universitaria Policlinico Umberto I, Roma, ASST Cremona, Cremona, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico, Milano, Ospedale di Circolo e Fondazione Macchi, Varese
المساهمون: Armando Gabrielli, Full Professor Internal Medicine
المصدر: TOFAcitinib Plus Hydroxycloroquine vs Hydroxycloroquine in Patients With Early Onset SARS-CoV2 (COVID-19) Interstitial Pneumonia:a Multicenter Randomized Controlled Open Label Trial
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT04390061Test
قاعدة البيانات: ClinicalTrials.gov
الوصف
الوصف غير متاح.